Back to 
NATIONAL BANK OF CANADA /FI/
NATIONAL BANK OF CANADA /FI/
BBIOShowing 0 of 3 quarters
Position history for NATIONAL BANK OF CANADA /FI/'s holdings in BRIDGEBIO PHARMA INC
No. National Bank of Canada exited its BBIO (Bridgebio Pharma) position in Q2 2022. Its Q1 2022 13F listed 346 shares worth $4,000. National Bank of Canada already held BBIO in its Q4 2021 13F, the earliest on record, and held it in 2 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of BBIO: VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC